# Exagen Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Exagen Inc.](/companies/xgn.md) (CIK 1274737)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 08:31 ET
- Period: 2023-12-31
- Accession: 0001274737-24-000028
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000028/a2024def14aproxystatement.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000028/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1274737/000127473724000028/a2024def14aproxystatement.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001274737-24-000028. Last ingested by Listed: Nov 15, 2026, 04:30 ET. No prices; not investment advice.
